Clinical evaluation of the efficacy of fractional radiofrequency for the treatment and reduction of stretchmarks: A prospective study. Skin resurfacing with fractional radiofrequency results in reepithelization, collagen shrinkage, fibroblast stimulation, and neocollagenesis which may be beneficial for the improvement of various skin lesions. This clinical study was conducted to evaluate age 36.2 years) received 4 FRF treatments on multiple different body zones with multiple passes over stretchmarks on the abdomen, inner arms, lower buttocks, inner thighs, and/or flanks. Analysis of 3D photographs of the striae affected zones at 16-week FU revealed an average reduction in the striae volume of 19.1%, a reduction of redness of 14.3%, a reduction of pigmentation of 11.2
Treatment of StretchMarks Using a New Formulation Combining Nanofractional Radiofrequency Plus Magnetic Nanofractional Radiofrequency. Stretchmarks are common atrophic dermal scars with significant physical and psychological effects. Therefore, there is a need for effective cosmetics and procedures for stretchmark treatment. This study aimed to evaluate the efficacy and safety of a novel treatment for stretchmarks that is made up of topical formulations containing beta-glucan combined with nanofractional radiofrequency. This randomized, blinded control trial enrolled 64 Chinese women aged 20-45 years at > 6 months after delivery with obvious white or silver abdominal stretchmarks. Participants were randomly allocated to group A (blank group), group B (topical product group), group C
Do any topical agents help prevent or reduce stretchmarks? Do any topical agents help prevent or reduce stretchmarks?Toggle navigationShared more. Cited more. Safe forever. * * advanced search * submit works * about * help * contact us * loginToggle navigationView Item * MOspace Home * University of Missouri-Columbia * School of Medicine (MU) * Department of Family and Community Medicine (MU Popular AuthorsStatistics by ReferrerDo any topical agents help prevent or reduce stretchmarks?Moore, JeanneKelsberg, GarySafranek, SarahView/OpenTopicalAgentsReduceStretchMarks.pdf (308.1Kb)Date2012FormatArticleMetadata[+] Show full item recordAbstractNo topical agent has been proven to prevent or reduce stretchmarks. Randomized controlled trials (RCTs) show that cocoa butter doesn't prevent stretch
Tasmannia lanceolata leaf extract alleviates stretchmark appearance in a randomized, placebo-controlled clinical trial in women and stimulates extracellular matrix synthesis in ex vivo human skin explants. The leaves of Tasmannia lanceolata mainly contain polygodial that is known to exhibit a range of biological functions including anti-inflammatory effects. These studies aimed to assess the effects of Tasmannia lanceolata extract (TLE) on skin and more particularly on stretchmarks in women. A double-blind, randomized, placebo-controlled clinical study was carried out on 29 women, aged from 25 to 60 years, to investigate the effects of TLE on stabilized stretchmarks. TLE and placebo products were topically applied daily for 8 weeks. Skin roughness and firmness of stretchmarks were
Development of a combination therapy with silanols complexed with boron citrate and ablative-fractional laser for treatment of wrinkles and stretchmarks. The twenty first century's progress in medicine and cosmetology triggered the search for effective and safe new cosmetics and procedures to fight with such problems as wrinkles or stretchmarks. The study aimed to use the synergy of silanols with boron compounds and to develop treatment methods supported by a fractional-ablative laser. Sixty-seven Caucasian people were enrolled in this study: 33 patients with facial and neck wrinkles and 34 patients with stretchmarks. Preparations containing methylsilanetriol were pressed into the skin by means of oxygen infusion which were followed by the fractional-ablative laser treatments
Clinical and immunohistochemical comparative study of the efficacy of carboxytherapy vs platelet-rich plasma in treatment of stretchmarks. Striae distensae are dermal scars with a linear atrophic depression. The exact origin of striae distensae remains unrevealed, but low expression of collagen and fibronectin genes in the affected tissue was found. Several treatment modalities have been proposed, yet no consistent modality is available. To evaluate and compare the efficacy and safety of carboxytherapy vs platelet-rich plasma (PRP) in treatment of stretchmarks. This study included 20 patients with striae alba. Every patient received treatment in the form of PRP injection in their right side (group A) and carboxytherapy session in their left side (group B) every 3-4 weeks for 4 sessions
Calcium Hydroxylapatite Combined with Microneedling and Ascorbic Acid is Effective for Treating StretchMarksStretchmarks can have a negative psychological impact on some individuals. Methods are available for treating stretchmarks, but high-quality evidence supporting their use is limited. We treat stretchmarks using injections of diluted calcium hydroxylapatite (CaHA, Radiesse) filler in stretchmark appearance ( < 0.001). Subjects were very satisfied (n = 22; 62.9%), satisfied (n = 8; 22.9%), neither satisfied nor dissatisfied (n = 4; 11.4%), or unsatisfied (n = 1; 2.8%) with their treatment results. Analysis revealed a significant correlation between Scar Scale scores and Patient Satisfaction scores (r = 0.483; = 0.003). Skin biopsies showed increased quantity and quality of collagen
The effectiveness of herbal medicines in preventing stretchmarks during pregnancy: a systematic review and meta-analysis PROSPERO International prospective register of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms
The use of anti stretchmarks' products by women in pregnancy: a descriptive, cross-sectional survey. Stretchmarks (Striae gravidarum) are a cutaneous change occurring commonly during pregnancy. A variety of products are available and promoted as ways to prevent or reduce their development, but it is not clear what products are used most commonly. The objective of this study was to identify women at 36 weeks gestation or more were included in the analyses. Descriptive and inferential statistical analyses were undertaken. Most respondents (n = 589, 78.2 %) indicated that they used a product to prevent or reduce the development of stretchmarks during their current pregnancy. A large range of products were used and more than one third of women (n = 210, 36.5 %) had used two or more
Topical management of striae distensae (stretchmarks): prevention and therapy of striae rubrae and albae. Striae distensae (SD) are common dermal lesions, with significant physical and psychological impact. Many therapeutic modalities are available but none can completely eradicate SD. The most common therapy is the application of topicals used both therapeutically and prophylactically. Even
Stretchmarks during pregnancy: a review of topical prevention. Striae gravidarum (SG), or stretchmarks developing during pregnancy, affect up to 90% of women. While not medically dangerous, SG can be disfiguring, causing emotional and psychological distress. However, studies specifically addressing the prevention of SG, especially during pregnancy, are sparse. Furthermore, the molecular
Clinical Evaluation of the Efficacy of Fractional Radiofrequency for the Treatment and Reduction of StretchMarks This is a prospective, single centre, evaluator-blind study of the performance of fractional radiofrequency (RF) for the treatment and revision of stretchmarks. The study will evaluate the progress of 15 subjects requesting treatment of stretchmarks. The study will involve four
A double-blind controlled clinical trial assessing the effect of topical gels on striae distensae (stretchmarks): a non-invasive imaging, morphological and immunohistochemical study. Striae distensae (SD) are cutaneous lesions often presenting post-pregnancy with atrophy and flattening of the epidermis. SD is poorly understood and treatment remains ill-defined. Our aim was to assess the effect
Use of a specific anti-stretchmark cream for preventing or reducing the severity of striae gravidarum. Randomized, double-blind, controlled trial. Few studies have tested the efficacy of commercially available cosmetic products for preventing striae gravidarum. Therefore, the objective of this study was to evaluate efficacy on prevention of striae gravidarum using a specific anti-stretchmark (cream without the active ingredients). Overall incidence of stretchmarks during pregnancy was 33.3% for the control group and 37.6% for the treated group (n.s.). Severity of previous stretchmarks significantly increased in the control group during the study (17.8%, P = 0.001), but not in the treated group (6.3%, ns). In women who developed new stretchmarks during the study
Assessment methods for stretchmarks in adults: a systematic review Assessment methods for stretchmarks in adults: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission
rarely lead to serious side effects such as thinning of the skin, adrenal suppression or very rarely Cushing’s syndrome, due to systemic absorption. The incidence of these more serious side effects is linked to the amount, potency and duration of use of the topical steroid. Thinned skin appears translucent with visible tiny blood vessels and may be more fragile and more susceptible to stretchmarks that the individual will require oral steroid therapy replacement. Cushing’s syndrome manifests with the development of a red, puffy, rounded face, acne and excessive facial and body hair, high blood pressure, weight gain, stretchmarks, slow wound healing and frequent infections. Patients, particularly those who require prolonged use or are using very potent topical steroids, should be advised to look
, followed by the buccal mucosa and the tongue. The majority of the lesions were erosive, with isolated lesions being observed in 21 patients and a diffuse distribution in 14 patients. In many cases, white lesions in the form of plaques or stretchmarks were found. Only 16 and 3 cases of ulcerated and bullous lesions, respectively, were reported. Desquamative gingivitis-like gingival lesions (in 12
than 6 times per day from each breast on most days before being aware of having insufficient milk production. The proportions of proposed breast hypoplasia markers including atypical breast type, widely spaced breasts, breast asymmetry, stretchmarks on the breast and lack of pregnancy breast growth. We also estimated the odds of having breast hypoplasia markers in at-risk groups compared to reference groups, adjusting for covariates. Approximately 68% reported at least one atypical breast (270/399; 95% CI: 62.9%, 72.1%). Around 47% reported widely spaced breasts (212/449; 95% CI: 42.7%, 52.7%), 72% a lack of pregnancy breast growth (322/449; 95% CI: 68.3%, 77.4%), and 76% stretchmarks on the breast (191/250; 95% CI: 70.7%, 81.3%). Multiple logistic regression analyses identified being